NITHA THOMAS: Open Payments
NPI 1841766599 · TROY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$817 in 43 payments from 11 companies in 2025. Trend: 2023 $2,117 · 2024 $1,465 · 2025 $817
Food & beverage: $808Education: $9
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $184 |
| Alkermes, Inc. | 12 | $181 |
| ABBVIE INC. | 4 | $105 |
| Neurocrine BioSciences, Inc. | 3 | $75 |
| Teva Pharmaceuticals USA, Inc. | 3 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 1 | $39 |
| Corium, LLC | 3 | $38 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
Products named: CAPLYTA, ARISTADA, VRAYLAR, INGREZZA, UZEDY, ABILIFY MAINTENA, COBENFY, Azstarys.
Industry payments across MI — which companies pay providers there.
